Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
2YXF
DownloadVisualize
BU of 2yxf by Molmil
The high resolution crystal structure of beta2-microglobulin under physiological conditions
Descriptor: Beta-2-microglobulin
Authors:Iwata, K, Matsuura, T, Nakagawa, A, Goto, Y.
Deposit date:2007-04-26
Release date:2007-10-30
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (1.13 Å)
Cite:High-resolution Crystal Structure of {beta}2-Microglobulin Formed at pH 7.0
J.Biochem.(Tokyo), 142, 2007
2D4D
DownloadVisualize
BU of 2d4d by Molmil
The Crystal Structure of human beta2-microglobulin, L39W W60F W95F Mutant
Descriptor: Beta-2-microglobulin, SODIUM ION
Authors:Iwata, K, Matsuura, T, Nakagawa, A, Goto, Y.
Deposit date:2005-10-17
Release date:2006-08-08
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (2.1 Å)
Cite:Conformation of Amyloid Fibrils of beta2-Microglobulin Probed by Tryptophan Mutagenesis
J.Biol.Chem., 281, 2006
2D4F
DownloadVisualize
BU of 2d4f by Molmil
The Crystal Structure of human beta2-microglobulin
Descriptor: Beta-2-microglobulin, SODIUM ION
Authors:Iwata, K, Matsuura, T, Nakagawa, A, Goto, Y.
Deposit date:2005-10-18
Release date:2006-08-08
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (1.7 Å)
Cite:Conformation of Amyloid Fibrils of beta2-Microglobulin Probed by Tryptophan Mutagenesis
J.Biol.Chem., 281, 2006
1VCK
DownloadVisualize
BU of 1vck by Molmil
Crystal structure of ferredoxin component of carbazole 1,9a-dioxygenase of Pseudomonas resinovorans strain CA10
Descriptor: FE (III) ION, FE2/S2 (INORGANIC) CLUSTER, HYDROSULFURIC ACID, ...
Authors:Nam, J.-W, Noguchi, H, Fujiomoto, Z, Mizuno, H, Fushinobu, S, Kobashi, N, Iwata, K, Yoshida, T, Habe, H, Yamane, H, Omori, T, Nojiri, H.
Deposit date:2004-03-09
Release date:2005-03-01
Last modified:2023-12-27
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Crystal structure of the ferredoxin component of carbazole 1,9a-dioxygenase of Pseudomonas resinovorans strain CA10, a novel Rieske non-heme iron oxygenase system
PROTEINS, 58, 2005
1IU9
DownloadVisualize
BU of 1iu9 by Molmil
Crystal structure of the C-terminal domain of aspartate racemase from Pyrococcus horikoshii OT3
Descriptor: CALCIUM ION, aspartate racemase
Authors:Liu, L, Iwata, K, Yohda, M, Miki, K.
Deposit date:2002-02-28
Release date:2003-09-09
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (2.04 Å)
Cite:Structural insight into gene duplication, gene fusion and domain swapping in the evolution of PLP-independent amino acid racemases
FEBS LETT., 528, 2002
1JFL
DownloadVisualize
BU of 1jfl by Molmil
CRYSTAL STRUCTURE DETERMINATION OF ASPARTATE RACEMASE FROM AN ARCHAEA
Descriptor: ASPARTATE RACEMASE
Authors:Liu, L.J, Iwata, K, Kita, A, Kawarabayasi, Y, Yohda, M, Miki, K.
Deposit date:2001-06-21
Release date:2002-06-05
Last modified:2011-07-13
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Crystal structure of aspartate racemase from Pyrococcus horikoshii OT3 and its implications for molecular mechanism of PLP-independent racemization.
J.Mol.Biol., 319, 2002
1HZ3
DownloadVisualize
BU of 1hz3 by Molmil
ALZHEIMER'S DISEASE AMYLOID-BETA PEPTIDE (RESIDUES 10-35)
Descriptor: A-BETA AMYLOID
Authors:Zhang, S, Iwata, K, Lachenmann, M.J, Peng, J.W, Li, S, Stimson, E.R, Lu, Y, Felix, A.M, Maggio, J.E, Lee, J.P.
Deposit date:2001-01-23
Release date:2001-01-31
Last modified:2024-05-22
Method:SOLUTION NMR
Cite:The Alzheimer's peptide a beta adopts a collapsed coil structure in water.
J.Struct.Biol., 130, 2000
2E8D
DownloadVisualize
BU of 2e8d by Molmil
3D Structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR
Descriptor: Beta-2-microglobulin
Authors:Fujiwara, T.
Deposit date:2007-01-19
Release date:2007-02-13
Last modified:2024-05-01
Method:SOLID-STATE NMR
Cite:3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR
Proc.Natl.Acad.Sci.Usa, 103, 2006
6P5P
DownloadVisualize
BU of 6p5p by Molmil
Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent
Descriptor: 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one, Rho-associated protein kinase 2
Authors:Hoffman, I.D, Skene, R.J.
Deposit date:2019-05-30
Release date:2020-01-15
Last modified:2023-10-11
Method:X-RAY DIFFRACTION (3.3 Å)
Cite:Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent.
J.Med.Chem., 63, 2020
6P5M
DownloadVisualize
BU of 6p5m by Molmil
Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent
Descriptor: 6-(5-methyl-1H-pyrazol-4-yl)-2-[(pyrrolidin-1-yl)methyl]thieno[3,2-d]pyrimidin-4(3H)-one, Rho-associated protein kinase 2
Authors:Hoffman, I.D, Skene, R.J.
Deposit date:2019-05-30
Release date:2020-01-15
Last modified:2023-10-11
Method:X-RAY DIFFRACTION (2.65 Å)
Cite:Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent.
J.Med.Chem., 63, 2020
8Z8M
DownloadVisualize
BU of 8z8m by Molmil
Crystal structure of human TNF alpha in complex with TNF30(VHH) domain of ozoralizumab
Descriptor: TNF30:VHH, Tumor necrosis factor
Authors:Mima, M, Mishima-Tsumagari, C.
Deposit date:2024-04-22
Release date:2024-09-04
Method:X-RAY DIFFRACTION (2.59 Å)
Cite:Structural design of the anti-TNF alpha therapeutic NANOBODY® compound, ozoralizumab, to support its potent and sustained clinical efficacy.
Biochem.Biophys.Res.Commun., 734, 2024
8Z8V
DownloadVisualize
BU of 8z8v by Molmil
Crystal structure of human serum albumin in complex with ALB8(VHH) domain of ozoralizumab
Descriptor: ALB8:VHH, Serum albumin
Authors:Mima, M, Mishima-Tsumagari, C.
Deposit date:2024-04-22
Release date:2024-09-04
Method:X-RAY DIFFRACTION (2.05 Å)
Cite:Structural design of the anti-TNF alpha therapeutic NANOBODY® compound, ozoralizumab, to support its potent and sustained clinical efficacy.
Biochem.Biophys.Res.Commun., 734, 2024
1J1I
DownloadVisualize
BU of 1j1i by Molmil
Crystal structure of a His-tagged Serine Hydrolase Involved in the Carbazole Degradation (CarC enzyme)
Descriptor: meta cleavage compound hydrolase
Authors:Habe, H, Morii, K, Fushinobu, S, Nam, J.W, Ayabe, Y, Yoshida, T, Wakagi, T, Yamane, H, Nojiri, H, Omori, T.
Deposit date:2002-12-05
Release date:2003-06-17
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (1.86 Å)
Cite:Crystal structure of a histidine-tagged serine hydrolase involved in the carbazole degradation (CarC enzyme).
Biochem.Biophys.Res.Commun., 303, 2003

225158

PDB entries from 2024-09-18

PDB statisticsPDBj update infoContact PDBjnumon